Statistics

Total Visits

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program55

Select a period of time:

Number of views in the range

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program14

Views

Views
September 20253
October 20252
November 20252
December 20251
January 20263
February 20261
March 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
United Kingdom3
Argentina3
Brazil2
Austria1
Finland1
 

Top cities views

Views
Buenos Aires1
Canoinhas1
Dallas1
Diamantina1
Helsinki1
Los Polvorines1
Zárate1